HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Papers In Press, published online ahead of print May 1, 2005
J. Lipid Res., doi:10.1194/jlr.M400496-JLR200

This Article Full Text Full Text (PDF) Supplemental data Supplemental Data All Versions of this Article: M400496-JLR200v1 46/5/969    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boullier, A. Articles by Quehenberger, O. Search for Related Content PubMed PubMed Citation Articles by Boullier, A. Articles by Quehenberger, O. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 46, 969-976, May 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

Phosphocholine as a pattern recognition ligand for CD36^1,

Agnès Boullier^2,*, Peter Friedman^2,, Richard Harkewicz, Karsten Hartvigsen^*, Simone R. Green^*, Felicidad Almazan^*, Edward A. Dennis, Daniel Steinberg^*, Joseph L. Witztum^* and Oswald Quehenberger^3,*

^* Department of Medicine, University of California San Diego, La Jolla, CA 92093-0682
Departments of Chemistry, Biochemistry, and Pharmacology, University of California San Diego, La Jolla, CA 92093-0682

¹ Trudy Forte served as Guest Editor for this manuscript.

The online version of this article (available at http://www.jlr.org) contains an additional table and two figures.

Published, JLR Papers in Press, February 1, 2005. DOI 10.1194/jlr.M400496-JLR200

² A Boullier and P. Friedman contributed equally to this work.

³ To whom correspondence should be addressed. e-mail: oquehenberger{at}ucsd.edu

We have previously shown that CD36 recognizes oxidation products of phospholipids on oxidized LDL (OxLDL) such as 1-palmitoyl-2-(5'-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC). The current study was designed to examine whether the phosphocholine (PC) headgroup in POVPC constitutes an obligatory binding target for CD36. To examine the contribution of PC in the binding of POVPC to CD36, we used well-defined synthetic oxidized phospholipids (OxPLs) cross-linked to BSA or to a hexapeptide. The OxPL adducts were then tested for their ability to bind to CD36-transfected cells and for their ability to inhibit OxLDL binding to CD36. Both POVPC-BSA and POVPC-peptide adducts were high-affinity ligands for CD36 and potent inhibitors of OxLDL binding. Enzymatic removal of the entire PC moiety of the POVPC-peptide, or of the choline headgroup alone, as well as substitution of the choline headgroup by ethanolamine abrogated the inhibitory activity of POVPC. Interestingly, PC by itself or cross-linked to BSA did not show any intrinsic competition activity.

In conclusion, our data demonstrate that the PC headgroup of OxPL alone is sufficient for binding to CD36, but only if presented in the correct conformation as in OxPL of OxLDL or as in POVPC-peptide adducts.

Abbreviations: Ac-TGTKGY, Ac-threonine-glycine-threonine-lysine-glycine-tyrosine; apoE, apolipoprotein E; KLH, keyhole limpet hemocyanin; OxLDL, oxidized low density lipoprotein; OxPL, oxidized phospholipid; PAMP, pathogen-associated molecular pattern; PC, phosphocholine; PLC, phospholipase C; PLD, phospholipase D; POVG, 1-palmitoyl-2-(5'-oxovaleroyl)-glycerol; POVPA, 1-palmitoyl-2-(5'-oxovaleroyl)-sn-glycero-3-phosphatidic acid; POVPC, 1-palmitoyl-2-(5'-oxovaleroyl)-sn-glycero-3-phosphocholine; POVPE, 1-palmitoyl-2-(5'-oxovaleroyl)-sn-glycero-3-phosphoethanolamine

Supplementary key words scavenger receptor • oxidized phospholipids • atherosclerosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Cocco and D. Chu Rimonabant may induce atrial fibrillation BMJ, June 12, 2009; 338(jun12_1): b1061 - b1061. [Full Text]

				L. K. Curtiss and P. S. Tobias Emerging role of Toll-like receptors in atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S340 - S345. [Abstract] [Full Text] [PDF]

				K. Hartvigsen, M.-Y. Chou, L. F. Hansen, P. X. Shaw, S. Tsimikas, C. J. Binder, and J. L. Witztum The role of innate immunity in atherogenesis J. Lipid Res., April 1, 2009; 50(Supplement): S388 - S393. [Abstract] [Full Text] [PDF]

				C. Bergmark, A. Dewan, A. Orsoni, E. Merki, E. R. Miller, M.-J. Shin, C. J. Binder, S. Horkko, R. M. Krauss, M. J. Chapman, et al. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma J. Lipid Res., October 1, 2008; 49(10): 2230 - 2239. [Abstract] [Full Text] [PDF]

				R. Harkewicz, K. Hartvigsen, F. Almazan, E. A. Dennis, J. L. Witztum, and Y. I. Miller Cholesteryl Ester Hydroperoxides Are Biologically Active Components of Minimally Oxidized Low Density Lipoprotein J. Biol. Chem., April 18, 2008; 283(16): 10241 - 10251. [Abstract] [Full Text] [PDF]

				B. G. Gugiu, K. Mouillesseaux, V. Duong, T. Herzog, A. Hekimian, L. Koroniak, T. M. Vondriska, and A. D. Watson Protein targets of oxidized phospholipids in endothelial cells J. Lipid Res., March 1, 2008; 49(3): 510 - 520. [Abstract] [Full Text] [PDF]

				M. E. Greenberg, X.-M. Li, B. G. Gugiu, X. Gu, J. Qin, R. G. Salomon, and S. L. Hazen The Lipid Whisker Model of the Structure of Oxidized Cell Membranes J. Biol. Chem., January 25, 2008; 283(4): 2385 - 2396. [Abstract] [Full Text] [PDF]

				W.-J. Won, M. F. Bachmann, and J. F. Kearney CD36 Is Differentially Expressed on B Cell Subsets during Development and in Responses to Antigen J. Immunol., January 1, 2008; 180(1): 230 - 237. [Abstract] [Full Text] [PDF]

				R. Harkewicz, E. Fahy, A. Andreyev, and E. A. Dennis Arachidonate-derived Dihomoprostaglandin Production Observed in Endotoxin-stimulated Macrophage-like Cells J. Biol. Chem., February 2, 2007; 282(5): 2899 - 2910. [Abstract] [Full Text] [PDF]

				B. R. Mwaikambo, F. Sennlaub, H. Ong, S. Chemtob, and P. Hardy Activation of CD36 Inhibits and Induces Regression of Inflammatory Corneal Neovascularization. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4356 - 4364. [Abstract] [Full Text] [PDF]

				C. J. Binder, P. X. Shaw, M.-K. Chang, A. Boullier, K. Hartvigsen, S. Horkko, Y. I. Miller, D. A. Woelkers, M. Corr, and J. L. Witztum Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis J. Lipid Res., July 1, 2005; 46(7): 1353 - 1363. [Abstract] [Full Text] [PDF]